SCHEMBL12897516

SCHEMBL12897516

COc1ccccc1C1CCN(C2CC(c3ccccc3)C(c3ccccc3)C2)CC1

nearest known ligand 0.54

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 8/20 0.54
KMT2A Q03164 8/20 0.54
DRD2 P14416 1/20 0.52
HTR2C P28335 2/20 0.49
MCOLN2 Q8IZK6 1/20 0.48
MCOLN3 Q8TDD5 1/20 0.48
MCOLN1 Q9GZU1 1/20 0.48
TRPV6 Q9H1D0 1/20 0.47
CHRNA7 P36544 1/20 0.47
CHRM4 P08173 2/20 0.46
CHRM1 P11229 2/20 0.46
CHRM2 P08172 1/20 0.45
KDM4E B2RXH2 1/20 0.45
ALDH1A1 P00352 1/20 0.45
ATM Q13315 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12897171 0.85 KDM4E (0.60) MEN1KMT2ADRD2HTR2CTRPV6
SCHEMBL12896502 0.85 DRD2 (0.56) MEN1KMT2ADRD2HTR2CMCOLN2
SCHEMBL12896927 0.83 HTR2C (0.55) MEN1KMT2ADRD2HTR2CMCOLN2
SCHEMBL12896451 0.81 MEN1 (0.59) MEN1KMT2ADRD2HTR2CMCOLN2
SCHEMBL12897089 0.81 DRD2 (0.55) MEN1KMT2ADRD2HTR2CMCOLN2
SCHEMBL12897275 0.81 DRD2 (0.55) MEN1KMT2ADRD2HTR2CMCOLN2
SCHEMBL7890862 0.80 MEN1 (0.61) MEN1KMT2ADRD2HTR2CMCOLN2
SCHEMBL12897136 0.80 MEN1 (0.61) MEN1KMT2ADRD2HTR2CMCOLN2
SCHEMBL12896742 0.80 MEN1 (0.61) MEN1KMT2ADRD2HTR2CMCOLN2
SCHEMBL12896740 0.80 HTR2C (0.51) MEN1KMT2ADRD2HTR2CMCOLN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7880007-B2 such as 1-bicyclo[2.2.1]hept-2-yl-4-(4-methoxy-2-methyl-phenyl)-piperidine, used for the treatment of chronic obstructive pulmonary disease, asthma, urinary incontinence, vision defects and Alzheimer's disease VERTEX PHARMACEUTICALS INCORPORATED (US) 2011-02-01 US disclosed
US-7880007-B2 such as 1-bicyclo[2.2.1]hept-2-yl-4-(4-methoxy-2-methyl-phenyl)-piperidine, used for the treatment of chronic obstructive pulmonary disease, asthma, urinary incontinence, vision defects and Alzheimer's disease VERTEX PHARMACEUTICALS INCORPORATED (US) 2011-02-01 US disclosed